5VM
5AM Venture Management Portfolio holdings
AUM
$260M
This Quarter Return
+32.45%
1 Year Return
+3.76%
3 Year Return
+144.87%
5 Year Return
+32.61%
10 Year Return
–
AUM
$260M
AUM Growth
+$260M
(-1.6%)
Cap. Flow
-$20.4M
Cap. Flow
% of AUM
-7.83%
Top 10 Holdings %
Top 10 Hldgs %
66.62%
Holding
31
New
–
Increased
–
Reduced
3
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
Enliven Therapeutics
ELVN
|
$11M |
| 2 |
AnaptysBio
ANAB
|
$6.65M |
| 3 |
Cidara Therapeutics
CDTX
|
$1.22M |
| 4 |
Dianthus Therapeutics
DNTH
|
$801K |
| 5 |
Entrada Therapeutics
TRDA
|
$672K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rallybio
RLYB
$22.4M
| $1.23M | 0.47% |
3,630,724
| – | – |
|
27
Adverum Biotechnologies
ADVM
$64.6M
| $1.16M | 0.45% |
541,666
| – | – |
|
28
Zentalis Pharmaceuticals
ZNTL
$122M
| $568K | 0.22% |
490,000
| – | – |
|
29
Mersana Therapeutics
MRSN
$36.5M
| $386K | 0.15% |
1,305,000
| – | – |
|
|
30
AnaptysBio
ANAB
$569M
| – | – |
-357,733
| Closed | -$6.65M |
|
|
31
Cidara Therapeutics
CDTX
$1.66B
| – | – |
-56,725
| Closed | -$1.22M |
|